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Abstract.  Mitogenesis,  cellular  aggregation,  and motil- 
ity follow upon the  interaction  of fibrinogen  with cer- 
tain  defined cell  surface receptors.  In addition  to cir- 
culating  platelets  and  vascular  endothelium,  monocytes 
express what appears  to be a  receptor  for fibrinogen. 
Evidence  is presented  here  that  the leukocyte adhesion 
receptor  Mac-1  can be specifically induced  to bind 
fibrinogen  with  characteristics  immunochemically  and 
functionally  distinct  from the established  Arg-Gly-Asp- 
directed  fibrinogen  receptors.  The  competence of Mac- 
1 as a  fibrinogen  receptor  is a  general  property  of 
cells of monocyte and  myeloid lineage  acquired  after 
maturational  changes  of some regions  of the  ~t subunit 
of Mac-1  during  the process of cell differentiation. 
This  ligand  recognition  specificity of Mac-1  is lacking 
for the resting  cell.  Rather,  induction  of fibrinogen 
binding  capacity  of Mac-1  is due to a  cellular  response 
to selected agonists  characterized  by inducing  rapid 
transients  of cytosolic Ca  2÷.  Although  different in acti- 
vation pathways and  recognition  specificity,  Mac-1  ex- 
hibits an  oligospecific ligand  versatility  characteristic 
of other  homologous  Arg-Gly-Asp-directed  adhesion 
receptors. 
variety of highly specific interactions between cells, as 
well as between cells and extracellular matrix, guide 
and  orientate  a  variety  of important  biological  re- 
sponses. Disparate processes including embryonic develop- 
ment (37), organ function (20), and immune and inflamma- 
tory  mechanisms  (32)  are  representative  of  fundamental 
cellular  processes requiring  participation  of general  adhe- 
sion mechanisms. A family of highly differentiated receptors 
modulate processes of cell-cell  communication  as well as 
cellular interaction  with extracellular  matrix.  These recep- 
tors designated "integrins" are members of a superfamily of 
homologous molecules one or more of which are synthesized 
and expressed by most if not all diploid cells (14). These are 
heterodimeric,  transmembrane  glycoproteins (GPs) ~, com- 
posed of noncovalently linked  a  and  13 subunits and  some 
functionally recognize the Arg-Gly-Asp (RGD) sequence in 
the context of contiguous residues as a ligand sequence (28). 
Common characteristics of the integrin family are their func- 
tional  versatility  and  ligand  multispecificity  (29).  High 
affinity saturable binding  of a  select few ligands,  i.e.,  oli- 
gospecificity, is exemplified by the platelet adhesion receptor 
GPIIb/IIIa which binds three different and nonhomologous 
adhesive proteins, i.e., fibrinogen, fibronectin and von Wil- 
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1. Abbreviations  used in this paper:  GP,  glycoprolein; Me2SO,  dimethyl- 
sulfoxide; vWE von Willebrand factor. 
lebrand factor (vWF), recognizing intramolecular loci with- 
in which is embedded a common RGD sequence.  Specific 
membrane  association  of these proteins  contributes  to the 
complex hemostatic response of the platelet (10, 24, 26). The 
principle of oligomolecular specificity is conserved among 
other  individual  integrins  even though  expressed by histo- 
genetically  distant  cell types and  associated with  different 
biological functions. Among the leukocyte subfamily of inte- 
grins,  i.e.,  Mac-l,  LFA-1, and p150,95  (30),  Mac-1 partici- 
pates  in  phagocytosis of opsonized particles  (4),  interacts 
with the complement degradation product C3bi (39), and has 
been implicated in a mechanism of cell migration and diape- 
desis (41). Further,  acquired  ligand binding  and biological 
function of Mac-1 has been demonstrated after appropriate 
stimulation.  Mac-1  then  serves as a  high  affinity  receptor 
for coagulation factor X  (1) and locally coordinates a rapid 
initiation  of the coagulation protease cascade (3).  A  more 
complex  interface  of the  leukocyte integrins  with  diverse 
adhesive  reactions  and  proteolytic  responses  is  hypothe- 
sized. We have observed that human monocytes appear to as- 
sociate with fibrinogen in a  receptor mediated fashion (2). 
These  observations  have been explored  further  to provide 
evidence that association of fibrinogen with cells of mono- 
cyte/myeloid lineage is attributable to Mac-1 per se, and that 
this  receptor  function  correlates  with  differentiation.  Fur- 
ther, selective cellular signaling eliciting rapid perturbations 
of cytosolic Ca  2÷ is associated with qualitative upregulation 
of Mac-1 and may be a relevant event in acquisition of spe- 
cific high  affinity receptor function. 
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Cells and Cell Culture 
Human  monocytes were prepared from EDTA-washed  peripheral blood 
mononuclear cells by adherence to sterile plastic petri dishes precoated with 
autologous serum as described previously (2). Cells were resuspended at 
1.5-2  x  107/ml in Iow-endotoxin, serum-free RPMI 1640 medium (Whit- 
taker M. A. Bioproducts, Walkersville,  MD) containing 20 mM Hepes (Cal- 
biochem Behring Diagnostic, La Jolla, CA),  100 I.tg/ml gentamycin (Ger- 
amycin, Schering Corp., Kenilworth, NJ).  The monoblast leukemia cell 
line U937  (27),  the monocytic leukemia cell line THP-I  (35)  (American 
Type Culture Collection, Rockville, MD), and the HL 60 promyelocytic 
leukemia cell line (7) were maintained in RPMI 1640,  10% FCS (HyClone, 
Logan, UT), 20 mM Hepes, 100 Ixg/ml gentamycin, 2 mM L-glutamine (Ir- 
vine Scientific, Santa Ana, CA), and 10 gM 2-mercaptoethanol (Eastman 
Kodak, Rochester, NY). U937 ceils were induced to a differentiated mono- 
cytic phenotype by culture for 1 or 3 d in complete media supplemented with 
5 ng/ml phorbol 12-myristate 13-acetate  (PMA, Sigma Chemical Co., St. 
Louis, MO). Granulocytic differentiation of HL 60 cells was obtained after 
4 d culture in media containing 1.25%  dimethylsulfoxide (Me2SO;  Sigma 
Chemical Co.) as described (7). In some experiments, platelets were iso- 
lated by the method of Mustard et al. (21) from freshly collected blood an- 
ticoagulated with acid/citrate dextrose solution and resuspended in Tyrode's 
albumin buffer,  pH 7.35,  at 4  x  10S/ml. 
Monoclonal Antibodies 
Monoclonal antibodies to the leukocyte adhesion receptors were: TS 1/18 
and 60.3 to the common 13 subunit shared by Mac-l, LFA-1, and p150,95 (25, 
30), and a panel specific for different regions on the ct subunit of Mac-I in- 
cluding 60.1 (36), M 1/70 (13), OKMI, OKM9, and OKM10 (39). The mono- 
clonal antibodies LJP5 and LIP9 are directed against epitopes of platelet 
GPIIb/IIIa involved in functionally independent interactions with the adhe- 
sive proteins fibrinogen and vWF (34). The monoclonal antibodies LM609 
and LM142 are specific for the vitronectin receptor expressed on endothelial 
cells (6). Control monoclonal antibody used in binding or inhibition experi- 
ment was the anti-class I MHC W6/32. 
Binding Reactions 
Purified human fibrinogen was radiolabeled with ~25I-sodium iodide (Amer- 
sham Corp., Arlington Heights, IL) by the Iodogen method (9) to a specific 
activity of 0.5-0.9 p,  Ci/p,g. The interaction of ~25I-fibrinogen with ADP (10 
I.tM)-stimulated  suspensions of washed platelets was studied as described 
by Niewiarowski et al. (22). The experimental procedures for the binding 
of ~25I-fibrinogen to monocytes have been reported elsewhere (2).  Typi- 
cally,  3-4  x  106 cells were stimulated with 10 I.tM ADP or ATP (Sigma 
Chemical Co.),  1 p.M of ionomycin (Calbiochem Behring), or 0.1-1 IIM 
of the chemotactic peptide fMLP (Sigma Chemical Co.) in the presence of 
1 mM CaCI2 immediately before the addition of various concentrations of 
~2sI-fibrinogen. After a  20-min incubation at room temperature, equilib- 
rium was reached and free and monocyte-bound fibrinogen were separated 
by centrifugation of aliquots of the incubation reaction through silicone oil. 
Nonspecific binding measured in the presence of a 50-fold excess of unla- 
beled fibrinogen was subtracted from the total. Similar analyses were per- 
formed with aliquots of each cell line. 
A synthetic peptide containing the RGD sequence (RGDV) was used in 
competitive inhibition analyses of ~25I-fibrinogen binding.  Different cell 
types stimulated with 10 p.M ADP were incubated with increasing concen- 
trations of RGDV (2.5  x  10-TM to  1  ×  10-3M) simultaneously with the 
addition of 0.14  gM  ~25I-fibrinogen. In antibody inhibition experiments, 
aliquots of cell suspensions were separately preincubated with saturating 
concentrations of each monoclonal antibody for 30 min at room temperature 
in the presence of 1 mM CaC12. After stimulation with 10 I.tM ADP, in- 
creasing concentrations of 125I-fibrinogen were  added  (0.017-0.44  IxM). 
The extent of ~25I-fibrinogen binding in the presence or absence of inhibi- 
tor was assayed after 20 min at room temperature. Reaction of the monoclo- 
nal antibodies with the monocyte surface was analyzed by indirect staining 
of the cell suspension. Briefly,  1 ×  106 monocytes or THP-I cells were in- 
cubated in V-bottomed microtiter plates (Costar Corp., Cambridge, MA) 
with predetermined saturating concentrations of each antibody tested for 30 
min at 4°C. After washes with FCS and RPMI 1640 containing 10% FCS, 
cells were incubated with fluorescein-conjugated goat (F(ab'h anti-mouse 
IgG for additional 30 min at 4°C. After washes in RPMI 1640, specific bind- 
ing of monoclonal antibodies to the cell surface was analyzed by flow cytom- 
etry on a Becton Dickinson IV/40 fluorescence activated cell sorter. 
Cell Surface Labeling and lmmunoprecipitation 
Platelets (4  x  108/ml) or monocytes (7-8  x  107/ml) were surface labeled 
with t2sI by the Iodogen method. After extensive washes with Hepes buffer 
(3.8 mM Hepes, 3.8 mM NaH2PO4,  0.137 M  NaCI, 2.7 mM KCI,  1 mM 
MgCI2, and 0.01% dextrose, pH 7.35) the cell pellet was resuspended in 1 
ml of lysis buffer containing 1% NP-40,  0.5% Triton X-100, 0.05 M Tris- 
HC1, 0.15 M NaC1, 0.1% BSA and 1 mM phenylmethylsulphonyl fluoride 
(PMSF), pH 8.3, for 30 min at 4°C. Cell nuclei and other cellular debris 
were removed by centrifugation at  14,000 g  for 20 min.  Aliquots of the 
platelet or monocyte lysate were separately incubated with LJP9 or LJP5 
antibody (300 ~g/ml) for 1 h at 37°C with agitation. Immune complexes 
were precipitated with preadsorbed purified rabbit anti-mouse immuno- 
globulins (Zymed Laboratories Inc., San Francisco, CA) conjugated with 
protein A-Sepharose CL 4B (Pharmacia Fine Chemicals, Uppsala, Swe- 
den) for 30 min at 4°C, extensively washed in PBS, pH 7.2,  and finally 
resuspended in 2 % SDS sample buffer,  pH 6.8, containing 50 mM 2-di- 
thiothreitol (DTT), boiled for 5 min at  100°C,  clarified at  14,000 g for 5 
min, and subjected to electrophoresis on 7.5%  polyacrylamide slab gels in 
0.1% SDS (16). Gels were stained with Coomassie Blue, destained, dried, 
and exposed for autoradiography at  -70°C using a Kodak X-Omat AR X 
ray film and intensifying screens (Cronex, E. I. DuPont de Nemours, Wil- 
mington, DE). 
Results 
Comparison Between the Monocyte Fibrinogen Receptor 
and Other Cell Adhesion Receptors 
Preliminary experiments analyzed the relationship between 
the monocyte fibrinogen receptor and other cell surface ad- 
hesive receptors.  Concentrations of monoclonal antibodies 
LJP9  and  LJP5  sufficient to functionally abolish the  func- 
tion  of platelet  GPIIb/IIIa  (150-200  ~g/ml)  (34)  did  not 
diminish the binding of fibrinogcn to stimulated  monocytes 
(Table I). Although both LJP9 and LJP5 immunoprecipitated 
the polypeptides corresponding  to the reduced platelet GPIlb/ 
IIIa from surface iodinated platelet lysate (Fig. l, lanes 3 and 
5),  neither  antibody  immunoprecipitated  any  identifiable 
molecules from surface-iodinated monocyte lysate (Fig.  l, 
lanes 4 and 6). 
Specific monoclonal antibody  binding studies  were also 
carried out to investigate  the possible monocyte surface ex- 
pression of another  cell adhesion receptor structurally  (ll) 
and  functionally  (6)  related  to GPIIb/IIIa;  i.e.,  the  vitro- 
nectin  receptor.  Two monoclonal  antibodies  (LM609  and 
LM142) which precipitate  the endothelial vitronectin recep- 
tor were used to analyze the monocytoid cell line THP-1 to 
avoid possible interference due to other blood cell contami- 
nation. Flow cytofluorometric analysis of the cell suspension 
with both antibodies  was consistently  negative  for the  ex- 
pression of the vitronectin receptor (Fig. 2). In contrast,  vir- 
tually all cells were positively stained by the monoclonal anti- 
body TS 1/18 against the ~ subunit of the leukocyte adhesion 
receptors Mac-l,  LFA-1, and p150,95  (30)  (Fig.  2). 
We  previously  reported  that  monocytes  fail  to  bind  fi- 
bronectin or vWF under  the same experimental conditions 
in which they bind fibrinogen (2), in marked distinction with 
the typical adhesive function of GPIIb/IIIa  (28). Therefore, 
the possibility that,  in addition to the immunologic differ- 
ences revealed  by monoclonal antibodies, the monocyte fi- 
brinogen receptor might also have a recognition specificity 
functionally distinct from GPIIb/IIIa-vitronectin  receptors 
was investigated  further. We examined the effect of the RGD- 
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J251-Fibrinogen Binding to Monocytes 
~2~I-Fibrinogen  bound (molecules/monocyte) 
~25I-Fibrinogen 
added  Control  LJP9  LJP5 
~M 
0.017  4,128  +  210  3,138  +  289  3,522  +  400 
0.035  9,293  +  843  7,481  +  513  8,407  +  1,210 
0.073  17,046  +  2,410  16,875  +  1,538  17,330  +  4,074 
0.14  33,527  +  4,534  35,203  +  1,681  32,297  +  3,708 
Aliquots  of monocytes  were separately  incubated  with saturating  concentrations  of LJP9 or LJP5 anti-platelet  GPIIb/Illa  monoclonal  antibodies  or control  antibody 
in the presence  of 1 mM CaCI2 for 30 min at room temperature. Increasing  concentrations  of ~25I-fibrinogen  0.017-0.14 ltM) were then added to the ADP (10 
pM) stimulated  cell suspension  and specific  binding was quantitated  at reached equilibrium  after 15 min incubation  at room temperature. 
containing  peptide  RGDV  on  t25I-fibrinogen  binding  to 
monocytes. RGDV inhibited with high efficiency the binding 
of fibrinogen to  ADP-stimulated platelets (IC50  =  5  pM) 
(Fig. 3).  In contrast, concentrations of RGDV as high as  1 
mM did not diminish fibrinogen binding to its complemen- 
tary receptor on ADP-stimulated monocytes (Fig.  3). 
Identification of  the Monocyte Fibrinogen Receptor in 
the Differentiation Molecule Mac4 
We hypothesized that the interaction of fibrinogen with mono- 
cytes might be associated with a  more general mechanisms 
of ligand binding or adhesion of these cells, implicating the 
leukocyte  class  of adhesion  receptors  Mac-l,  LFA-1,  and 
p150,95  (30).  Preincubation  of  the  cell  suspension  with 
saturating  concentrations  of the  monoclonal  antibody  TS 
1/18 to the common I~ subunit shared by all three heterodi- 
meric receptors inhibited fibrinogen binding to ADP-stimu- 
lated monocytes  (Fig. 4).  This  implicated one or more of 
these molecules as  responsible for the  interaction with  fi- 
brinogen.  However, individual receptor identity and ligand 
specificity is conferred by the associated tx subunit. A panel 
of monoclonal antibodies specific for different epitopes on 
the ct subunit of Mac-1  was analyzed for inhibition of ~25I- 
fibrinogen binding to  ADP-stimulated monocytes.  The  re- 
suits are summarized in Table II. Saturating concentrations 
of monoclonal  antibodies OKM1  and  M  1/70  inhibited fi- 
brinogen binding to stimulated cells (Table II). However, not 
all intramolecular loci of Mac-1 appear to be involved in the 
interaction with fibrinogen as revealed by the lack of inhibi- 
Figure 1.  Immunoprecipitation of platelet or monocyte 1251 surface- 
labeled components with anti-GPIIb/IIIa monoclonal antibodies. 
Aliquots of iodinated platelet or monocyte lysates were separately 
incubated  with  anti-GPIIb/IIIa monoclonal  antibodies LJP5  or 
LJP9 for 1 h at 37°C. The immune complexes were precipitated and 
further processed as described in Materials and Methods. Lanes 1 
and 2 contain aliquots of the platelet or monocyte iodinated lysate 
before immunoprecipitation, respectively. Lanes 3 and 5 are the re- 
duced antigens precipitated from the platelet lysate by LJP9 and 
LIP5  monoclonal  antibodies and  corresponding  to  GPIIb/IIIa. 
Lanes 4 and 6are the immunoprecipitates  with LJP9 and LJP5 from 
surface-iodinated monocyte lysate. Control experiment not shown 
in the figure revealed that OKMI monoclonal antibody precipitated 
the polypeptides corresponding to the ct and 13 subunit of Mac-I 
from  surface-iodinated monocyte lysate, under the same experi- 
mental conditions. 
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Figure 2. Indirect immunofluo- 
rescence  staining of THP-I cells 
with  antivitronectin receptor 
monoclonal  antibodies.  1  × 
106 cells were separately incu- 
bated with LM609 or LMI42 
monoclonal antibodies for 30 
min at 4°C, washed and stained 
with  aliquots  of fluorescein- 
conjugated  goat  anti-mouse 
immunoglobulins. The irrele- 
vant  monoclonal  antibody 
V82A6 or the monoclonal TS 
1/18 were the negative and pos- 
itive  controls,  respectively. 
Fluorescence  intensity  (ab- 
scissa FL/) quantifies the sur- 
face  expression  of the  anti- 
gen, the ordinate, and the cell 
number. 
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Figure 3. Effects of the synthetic peptide Arg-Gly-Asp-Val  (RGDV) 
on t25I-fibrinogen  binding to platelets or monocytes. Various doses 
of RGDV (2.5  x  10  -7 M to 1 x  10  -3 M) were mixed at equilib- 
rium with 10 taM ADP-stimulated suspensions ofplatelets or mono- 
cytes, simultaneously with a fixed concentration of ~zsI-fibrinogen 
(0.14 pM). The amount of ~25I-fibrinogen  bound in the absence of 
RGDV was considered  100% binding. The inhibition efficiency of 
RGDV was  calculated  by plotting  the  percent  of inhibition  of 
~25I-fibrinogen binding  to platelets  (o) or monocytes (m) vs. the 
logarithm of peptide concentration. 
tory effect of antibodies OKM9 and OKM10 directed against 
different epitopes on the ct subunit of Mac-1  (38). 
The apparent role of Mac-1 as a cellular receptor possess- 
ing a latent recognition specificity for fibrinogen inducible 
by stimulation of the cells with ADP was investigated by an 
additional  independent experimental approach. To exclude 
possible  participation,  either  direct  or  indirect,  by  other 
blood-derived cells and also to correlate cellular differentia- 
tion with the functional acquisition of fibrinogen-binding ca- 
pacity, two transformed cell lines of monocytic lineage were 
investigated. U937 cells were used as a monoblast precursor 
prototype expressing the least degree of monocytic differen- 
tiation (27); whereas THP-1 cells were used as a more mature 
monocytic  phenotype  (35).  ADP-stimulated  U937  bound 
~25I-fibrinogen in a specific and saturable fashion (Fig. 5 A). 
However,  the  number of molecules  of fibrinogen that as- 
sociated with the cell surface was only 10-13 % of that bound 
by freshly isolated monocytes under the same experimental 
conditions  (Fig.  4).  Consistently,  monoclonal  antibodies 
OKM1 (Fig. 5 B, upper panel, 1 ) and M  1/70 (Fig. 5 B, lower 
panel,  1) demonstrated only low density and frequency of 
these Mac-1 ct subunit epitopes on the surface of U937 cells. 
After differentiation of U937 cells with PMA into a more ma- 
ture  monocytic  phenotype,  fibrinogen  binding  increased 
three- to fourfold (Fig.  5 A).  This increased function was 
m ~  4o 
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Figure 4.  Effects of TS  1/18 
anti-13 subunit of Mac-l, LFA-I, 
and p150,95 monoclonal anti- 
body on J2sI-fibrinogen  binding 
to ADP-stimulated monocytes. 
Suspensions  of  monocytes 
were  incubated  with  saturat- 
ing concentrations of TS  1/18 
or control  antibody  (W6/32) 
for 30 min at room tempera- 
ture in the presence of 1 mM 
CaC12. After stimulation with 
10  I.tM ADP, increasing  concentrations  of t25I-fibrinogen were 
added (0.017-0.44 I.tM) and specific binding to control monocytes 
(o) or monocytes treated with TS 1/18 (m) was determined after a 
20-min incubation at room temperature. 
concordant with an increase of surface expression of the epi- 
topes of Mac-1 recognized by OKM1 and M  1/70 (Fig. 5 B, 
2), which were implicated in fibrinogen binding. No further 
change in fibrinogen-binding capacity or surface expression 
of Mac-1 ct subunit epitopes were observed when U937 were 
further cultivated for as long as 3 d in the presence of PMA 
(not shown). 
After brief stimulation with ADP, THP-1 cells bound fi- 
brinogen in a specific and saturable fashion (Fig. 6 A). Simi- 
lar to freshly isolated monocytes (Table II), monoclonal anti- 
bodies OKM1  and M  1/70 blocked binding of ~25I-fibrino- 
gen to THP-1 cells (Fig. 6 A). Consistent with a more mature 
phenotype than U937,  THP-1 that had not been exposed to 
differentiation promoters constitutively expressed the  epi- 
topes of Mac-1 implicated in the binding of fibrinogen as re- 
vealed by the high density and majority of cells reactive with 
antibodies OKM1 (Fig. 6 B, upper panel) and M  1/70 (Fig. 
6 B, lower panel) in indirect cytofluorometric analysis. 
The progressive maturation of the regions of Mac-1 medi- 
ating fibrinogen binding is quantitatively analyzed in Table 
III. Monoclonal antibodies TS  1/18 and 60.3 detected high 
levels of the [3 subunit of Mac-1 even at early stages of cell 
maturation. In contrast, the epitopes of the ct subunit of Mac-1 
functionally involved in fibrinogen binding and recognized 
by monoclonal antibodies M  1/70 and OKM1 progressively 
increased during the cell differentiation. Other aspects of the 
ct subunit of Mac-1 recognized by monoclonal antibody 60.1 
remained quantitatively unmodified (Table III). 
To determine whether inducible fibrinogen binding was a 
general property of cells expressing Mac-l, a relevant cell 
Table I11. Effects of Anti-a Subunit of Mac-1 Monoclonal Antibodies on 1251-Fibrinogen Binding to Monocytes 
12~I-Fibrinogen bound (molecules/monocyte) 
~251-Fibrinogen 
added  Control  OKMI  OKM9  OKMI0  M  1/70 
/aM 
0.017  4,128  +  210  853  -I-  221  4,024  ___  682  4,000  +  1,150  516  +  351 
0.035  9,293  +  843  2,811  -I-  859  8,648  _  367  10,439  +  1,876  1,069  +  605 
0.073  17,046  +  2,410  3,920  +  1,658  16,021  -I-  1,738  18,068  +  1,076  3,154  +  2,307 
0.147  33,527  +  4,534  10,728  +  2,768  30,000  +  4,202  32,185  +  2,690  4,465  4-  2,796 
Suspensions of monocytes were separately incubated with saturating concentrations of each anti-Mac-I  antibody in the presence of 1 mM CaCI2 for 30 min at 
room temperature.  Cells were stimulated with l0 I.tM ADP immediately before the addition of various doses of ~25I-fibrinogen. Specific binding in the presence 
of each antibody was measured as described. 
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Figure 5.  ~25I-fibrinogen  binding  to untreated  or PMA-differen- 
tiated U937 cells.  (A) Increasing concentrations  of 125I-fibrinogen 
(0.017-0.88 pM) were mixed with ADP-stimulated suspensions of 
U937 before (m) or after (e) 1 d culture in the presence of PMA. 
(B) Immunoreactivity of Mac-1 on untreated or PMA-differentiated 
U937 cells. Aliquots of each cell suspension were examined by flow 
cytometry  with  OKM1 (upper panel) or M  1/70 (lower panel) 
monoclonal  antibodies,  before  (1)  or after (2) differentiation of 
U937 induced by PMA. 
line of different differentiation was investigated.  The pro- 
myelocytic  leukemia  cell  line  HL  60  was  induced  with 
Me2SO to a  granulocyte stage of differentiation (7).  After 
stimulation with ADP,  these cells bound fibrinogen avidly 
(Fig.  7).  For  comparison,  the  amount  of  ~:5I-fibrinogen 
bound  by monocytes is also shown in  Fig.  6.  Me2SO-dif- 
ferentiated HL 60 bound about twofold more fibrinogen than 
monocytes, consistent with a quantitatively greater surface 
expression of Mac-1 on cells of myeloid phenotype as com- 
pared with monocytes (12). 
We have observed that induction of fibrinogen binding to 
cells of monocyte and myeloid phenotype is rapid and in- 
duced by ADP. Initial analyses of the mechanisms of cellular 
signaling  for this response revealed that concentrations of 
ADP able to induce fibrinogen binding to monocytes do not 
promote a mobilization of the large intracellular storage pool 
of Mac-1 to the plasma membrane (33), as demonstrated by 
the unchanged reactivity of a panel of anti-Mac-1 monoclo- 
nal antibodies before or after ADP stimulation (not shown). 
In addition to ADP, certain other mediators of rapid changes 
in the levels of intracellular cytosolic Ca  2÷ such as ionomy- 
cin (17) or the chemoattractant fMLP (15) also induced in 
monocytes, monocytoid cell lines, and granulocyte differen- 
tiated HL 60 cells specific fibrinogen binding to Mac-1 with 
characteristics  indistinguishable  from  those  observed  for 
ADP stimulation (Table IV). Notably, the triphosphate nu- 
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Figure 6. Effects of OKM1 anti-a subunit of Mac-1 monoclonal an- 
tibody on 125I-fibrinogen  binding to THP-1 cells. (A) Suspensions 
of THP-1 cells were incubated with control antibody (o) or OKM1 
antibody (m) before the addition of the stimulus (ADP) and various 
doses of 12sI-fibrinogen (0.017-0.88 pM). After a 20-min  incuba- 
tion,  specific  ~25I-fibrinogen binding  to  control  cells  or  cells 
treated with OKM1 was determined as described. (B) Immunoreac- 
tivity of Mac-1 on THP-1 cells. Monoclonal antibodies OKM1 (up- 
perpanel) or M 1/70 (lower  panel) were used in flow cytofluoro- 
metric  analysis  of suspensions  of THP-1 cells  to quantitate  the 
surface expression of the regions of Mac-1 functionally involved in 
fibrinogen binding at this stage of cell differentiation. 
cleotide ATE a known potent mobilizer of cytosolic Ca  2÷ in 
endothelial cells (18),  neutrophils (23),  and an inhibitor of 
fibrinogen binding to platelets (19) induced specific fibrino- 
gen binding to monocytes and monocytoid cells (Table IV). 
In the absence of extracellular calcium the responses were 
not observed, consistent with induction of calcium flux as 
one of the events involved in the acquisition of fibrinogen- 
binding capacity of monocytic and myelocytic cells. 
Discussion 
In this study we have examined the interaction of fibrinogen 
with monocytes within the context of the adhesive responses 
of these cells. Either in specific forms of cellular immunity 
or  during  the  complex mechanisms  of inflammation,  the 
monocyte is capable of a broad range of interactions. Among 
these,  monocytes specifically bind fibrinogen in a reaction 
implicating two classes of receptors with different affinities: 
1,910  high  affinity  sites  (Kd  =  4  nM)  and  120,500  low 
affinity sites (Kd  =  1.3  IxM) (2).  The monocyte fibrinogen 
receptor appeared to be only partially related to GPIIb/IIIa 
and  in fact functional  and  structural  differences suggested 
that the interaction of fibrinogen with platelets or monocytes 
might be mediated by different surface molecules (2).  The 
Table IlL Maturation of the Regions of  Mac-1 Involved in Fibrinogen Binding during the Process of Cell Differentiation 
Surface antigen density (percentage of positive cells) 
Monoclonal 
antibodies  Specificity  U937  PMA-treated  U937  THP-1 
TS  1/18  13  subunit Mac-1  84.7  +  1.5  88.5  +  8.12  93.6  +  5.6 
60.3  13  subunit Mac-1  83.1  +  2  88.9  +  7.5  87.6  +  5.7 
60.1  a  subunit Mac-I  60.8  +  1.4  63  +  7  84.9  +  4.8 
M  1/70  a  subunit Mac-1  20  +  0.7  42  +  4.3  73.1  +  13.7 
OKM1  ct  subunit Mac-1  46.3  +  4.4  70.2  -1-  10.1  60  4-  10.3 
Suspensions of U937 PMA-differentiated U937 or THP-I were separately incubated with each antibody for 30 min at 4°C before the addition of fluorescein-conju- 
gated goat anti-mouse IgG for an additional 30 min at 4°C. After washes, cells were analyzed by flow cytometry  for surface expression of the antigens. 
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CaCI2.  Increasing  concentrations  of  '2q-fibrinogen were 
added (0.017-0.44 I.tM) and the reaction was terminated after 
min incubation at room temperature as described. 
Figure 7. Comparison between 
Me2SO-differentiated HL 60 
cells  and  freshly  isolated 
blood monocytes for the abil- 
ity to bind 'zq-fibrinogen. Sus- 
pensions of monoeytes (,,) or 
HL 60 cells cuRured for 4 d in 
the presence of Me2SO to in- 
duce differentiation into ma- 
0'~,  0~9  0.4  ture  granulocytes  (e),  were 
'"l.F~ri,,0~,  A~a lUM~  stimulated  with 10 I.tM ADP 
in  the  presence  of  1  mM 
then 
a 20- 
present study provides new and independent immunochemi- 
cal evidence that the monocyte fibrinogen receptor is entire- 
ly distinct from the platelet receptor for fibrinogen,  i.e., 
GPIIb/IIIa, and also independent from the related molecule 
on endothelial cells,  the vitronectin receptor (11). Rather, 
binding of fibrinogen to monocytes is mediated by Mac-1. In- 
hibition of fibrinogen binding to monocytes by monoclonal 
antibody TS 1/18 implicates the leukocyte class of adhesion 
receptors Mac-l, LFA-1, and p150,95 (30). Further, monoclo- 
nal antibodies OKM1 and M 1/70 to different epitopes on the 
~t subunit of Mac-1  inhibited fibrinogen binding to mono- 
cytes confirming the identity of Mac-1 as a fibrinogen recep- 
tor, and that as for other integrins (11) the ligand specificity 
for this  receptor is  governed by the particular a  subunit. 
Notably, OKM10 monoclonal antibody, an efficient inhibitor 
of the interaction of C3bi with Mac-1 (39), failed to diminish 
'25I-fibrinogen binding to monocytes suggesting that certain 
different intramolecular loci in the a  subunit of Mac-1  are 
critical to binding of these two different ligands. 
The role of Mac-1  as a  leukocyte-distributed fibrinogen 
receptor was also confirmed and substantiated by studying a 
variety of transformed  cell  lines  with  monocyte-myeloid 
characteristics. In a system free of blood-derived cell con- 
tamination, U937, THP-1, and granulocytic differentiated HL 
60 cells bound |2q-fibrinogen after appropriate stimulation 
in a reaction consistently inhibited by monoclonal antibodies 
OKM1 and M 1/70. However, the different slopes of differen- 
tiation of the cells examined emphasizes how the inducible 
functional capacity of Mac-1  to interact with fibrinogen is 
related to the process of maturation and differentiation of the 
receptor per se, as reflected by the concordant increase of 
fibrinogen-binding  capacity and the epitopes defined by mono- 
clonal antibodies OKM1  and M  1/70. 
Whether or not Mac-1  receptor recognition of fibrinogen 
might occur through recognition of a region with an embed- 
ded RGD sequence as suggested for C3bi (40) is not known. 
However, the short peptide RGDV, an efficient inhibitor of 
the  interaction  of  fibrinogen  with  the  platelet  receptor 
GPIIb/IIIa was  ineffective in  inhibiting the association of 
fibrinogen with Mac-1.  Short RGD peptides have also been 
ineffective in inhibiting C3bi association with Mac-1  (38). 
Further, we have observed that longer RGD peptides based 
on the sequence of C3bi (40) or the RGD-related peptide of 
the COOH terminus of the 3, chain of fibrinogen (31) produce 
no competitive inhibition of fibrinogen binding to leukocytes 
for concentrations up to 0.5 mM (our unpublished observa- 
tions), suggesting a specific recognition specificity of Mac-1 
that is not identical to other RGD-directed receptors. 
We have recently established that Mac-1 also functions as an 
inducible high affinity receptor for factor X in a pathway that 
can lead to factor X activation and initiation of thrombin gener- 
ation on the cell surface (1, 3). We now demonstrate that under 
comparable conditions, Mac-1 binds fibrinogen. Fibrinogen, 
C3bi, and factor X mutually inhibit one another for binding 
to Mac-l,  (reference l,  and our unpublished observations) 
and anti-Mac-1  antibodies  can immunoprecipitate '25I-fibrino- 
gen chemically cross-linked to its complementary receptor 
on the cell surface (our unpublished observations), confirm- 
ing the role of Mac-1  as an oligospecific cellular receptor. 
The local concentration of fibrinogen on the cell  surface 
resulting from Mac-1 binding could facilitate more efficient 
conversion to fibrin, thus rendering more efficient the local 
generation of low levels of thrombin. Hypothetically, the high 
concentration of fibrinogen in plasma should competitively 
inhibit binding of factor X; however, sufficient factor X bind- 
ing and activation occurs to support the initiation of a vigor- 
ous procoagulant response upon exposure of these cells to 
ADE The basis is not yet known for the relatively greater 
efficiency of factor X  binding,  a  subject of more detailed 
analysis of binding kinetics. As for IL-1 stimulation of cellu- 
lar adhesion to endothelium, fibrinogen occupancy of Mac-I 
may play a role in the localization and diapedesis of mono- 
cytes and neutrophils in the extravascular compartment in a 
collaborative network of interactions with endothelial cells 
and endothelial cell-associated fibrinogen or fibrin (3,  8). 
The inducibility of Mac-1 binding of fibrinogen is compara- 
Table IV. Inducibility of t2Sl-Fibrinogen  Binding to THP-1 cells by Agonists Stimulating  Transients in Cytosolic Ca  2÷ 
tzSI-Fibrinogen bound (molecules/cell) 
125I-Fibrinogen 
added  ADP  ATP  fMLP  Ionomycin 
~M 
0.017  2,316  +  280  1,787  +  515  2,691  +  426  2,018  +  461 
0.035  4,013  +  828  4,142  +  816  5,594  +  355  4,497  +  604 
0.073  8,575  +  1,580  7,170  +  88  9,561  +  2,125  7,967  +  177 
0.14  16,374  +  4,881  14,523  _  2,125  12,747  +  2,130  17,564  +  3,694 
0.29  28,624  +  2,072  32,219  +  3,200  30,807  +  6,847  31,250  +  8,613 
0.44  43,674  +  8,287  46,597  +  7,425  43,674  +  10,146  41,608  +  9,767 
Aliquots of THP-1  cells were separately stimulated with 10 ktM ADP or ATP,  1 I.tM fMLP, or  I  ltM ionomycin in the presence of 1 mM CaCI: immediately 
before the addition of increasing concentrations of '2q-fibrinogen (0.017-0.44 IxM). Specific binding in the presence of each agonist was measured as described. 
Unstimulated cells or cells treated  with TNFa (200 U/ml) or AMP (10 p.M) did not specifically  bind eq-fibrinogen. 
The Journal of Cell Biology,  Volume 107,  1988  1898 ble to that for factor X  (1). Rapid transients in the cytosolic 
Ca  2÷ are suggested as early events leading to transition of 
this  receptor  from  a  relaxed  state  to  a  reconformed  high 
affinity state capable of avid interaction with ligand. In favor 
of this hypothesis, classic mobilizers of interacellular Ca  2+ 
and of Ca  :+ influx such as ionomycin (17) or fMLP (15) in- 
duce fibrinogen and factor X binding to Mac-l; and extracel- 
lular  Ca  2÷  is  required.  Other,  more  physiologic  agonists 
such as the adenine nucleotides ADP and ATP also induce 
fibrinogen and factor X  binding to Mac-1.  Both ADP and 
ATP  produce  transients  in  cytosolic  Ca  2+  in  endothelial 
cells (18) and neutrophils (23) through mobilization of intra- 
cellular stores and flux from the extracellular fluid.  Recent 
data (Altieri, D. C., and T. S. Edgington, manuscript in prepa- 
ration) indicate that these agonists produce similar mobiliza- 
tion and flux of Ca  2÷ in cells of monocytic lineage. 
In conclusion, signals involving qualitative cellular pertur- 
bations rapidly promote receptor activation of the integrin 
Mac-1.  These  reactions  involve  rapid  acquisition  of high 
affinity binding capacity  for fibrinogen and factor X.  The 
pattern of oligospecificity for ligands is a notable characteris- 
tic of this receptor which participates in diverse forms of mo- 
lecular assembly on the surface of cells of monocyte and my- 
eloid lineage and promote adhesive reactions. 
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